The details
Who it affects
R&D, data, and technology leaders at mid-sized and large biopharma companies with revenue above $500 million.p6
What holds them back
- Data leaders struggle to connect research data for AI because records sit in separate systems and incompatible formats.p64
- R&D leaders struggle to expand AI use because teams lack operational readiness and need training and human oversight.p57
- Regulatory teams struggle to prepare submissions efficiently because compiling data and writing reports involves substantial manual work.p31
The numbers
What people search for
- connect lab and clinical data for AI
- clean research data for AI
- AI training for pharma research teams
- automate clinical study report writing
- speed up regulatory submission paperwork



